Publication | Open Access
Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma
92
Citations
41
References
2022
Year
This study finds that cholesterol biosynthesis supports the expansion of cancer stem cell populations to drive resistance to tyrosine kinase inhibitor therapy in hepatocellular carcinoma, identifying potential therapeutic approaches for improving cancer treatment.
| Year | Citations | |
|---|---|---|
2008 | 5.8K | |
2018 | 5.3K | |
2007 | 1.2K | |
2008 | 1.2K | |
2010 | 702 | |
2011 | 587 | |
2018 | 442 | |
2007 | 432 | |
2016 | 372 | |
1996 | 315 |
Page 1
Page 1